IL54603A - Imidazolylalkyl(alkylthioalkyl)thiourea and guanidine derivatives,process for their preparation and pharmaceutical compositions containing them - Google Patents
Imidazolylalkyl(alkylthioalkyl)thiourea and guanidine derivatives,process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL54603A IL54603A IL54603A IL5460378A IL54603A IL 54603 A IL54603 A IL 54603A IL 54603 A IL54603 A IL 54603A IL 5460378 A IL5460378 A IL 5460378A IL 54603 A IL54603 A IL 54603A
- Authority
- IL
- Israel
- Prior art keywords
- imidazolylalkyl
- alkylthioalkyl
- thiourea
- preparation
- pharmaceutical compositions
- Prior art date
Links
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 title 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
- 150000002357 guanidines Chemical class 0.000 title 1
- 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
- C07C323/44—X or Y being nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB18881/77A GB1602458A (en) | 1977-05-05 | 1977-05-05 | Bisamidines as histamine h2-antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL54603A0 IL54603A0 (en) | 1978-07-31 |
| IL54603A true IL54603A (en) | 1982-12-31 |
Family
ID=10120038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL54603A IL54603A (en) | 1977-05-05 | 1978-05-01 | Imidazolylalkyl(alkylthioalkyl)thiourea and guanidine derivatives,process for their preparation and pharmaceutical compositions containing them |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US4212875A (en:Method) |
| JP (1) | JPS53141270A (en:Method) |
| AT (1) | AT365174B (en:Method) |
| BE (1) | BE866676A (en:Method) |
| CA (1) | CA1105027A (en:Method) |
| DE (1) | DE2819874A1 (en:Method) |
| DK (1) | DK192778A (en:Method) |
| FI (1) | FI781379A7 (en:Method) |
| FR (1) | FR2389608B1 (en:Method) |
| GB (1) | GB1602458A (en:Method) |
| HU (1) | HU176882B (en:Method) |
| IE (1) | IE46950B1 (en:Method) |
| IL (1) | IL54603A (en:Method) |
| IT (1) | IT1096207B (en:Method) |
| LU (1) | LU79606A1 (en:Method) |
| NL (1) | NL7804887A (en:Method) |
| NO (1) | NO781572L (en:Method) |
| SE (1) | SE7805092L (en:Method) |
| ZA (1) | ZA782367B (en:Method) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1574214A (en) | 1976-03-11 | 1980-09-03 | Smith Kline French Lab | Amidines |
| DE2905134A1 (de) | 1978-02-17 | 1979-08-23 | Degussa | Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest |
| US4309435A (en) * | 1978-10-16 | 1982-01-05 | Imperial Chemical Industries Ltd. | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
| EP0050407A1 (en) * | 1980-08-27 | 1982-04-28 | Glaxo Group Limited | 3,5-Disubstituted-1,2,4-triazole compounds, processes for their preparation and pharmaceutical compositions containing them |
| US4375547A (en) * | 1980-10-02 | 1983-03-01 | Eli Lilly And Company | N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine |
| US4382090A (en) * | 1980-10-02 | 1983-05-03 | Eli Lilly And Company | N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds |
| US4587344A (en) * | 1983-02-07 | 1986-05-06 | Eli Lilly And Company | Isothiourea synthesis process |
| DE3579000D1 (de) * | 1985-04-02 | 1990-09-06 | Heumann Pharma Gmbh & Co | Imidazolylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. |
| EP4196793A1 (en) | 2020-08-11 | 2023-06-21 | Université de Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1305549A (en:Method) * | 1969-10-29 | 1973-02-07 | ||
| US4062967A (en) * | 1974-02-07 | 1977-12-13 | Smith Kline & French Laboratories Limited | Bis-guanidino-alkane compounds |
| GB1497260A (en) * | 1974-06-28 | 1978-01-05 | Smith Kline French Lab | Guanidine derivatives |
-
1977
- 1977-05-05 GB GB18881/77A patent/GB1602458A/en not_active Expired
-
1978
- 1978-04-25 ZA ZA00782367A patent/ZA782367B/xx unknown
- 1978-05-01 IL IL54603A patent/IL54603A/xx unknown
- 1978-05-02 FR FR7812985A patent/FR2389608B1/fr not_active Expired
- 1978-05-02 US US05/902,145 patent/US4212875A/en not_active Expired - Lifetime
- 1978-05-03 NO NO781572A patent/NO781572L/no unknown
- 1978-05-03 DK DK192778A patent/DK192778A/da unknown
- 1978-05-03 SE SE7805092A patent/SE7805092L/xx unknown
- 1978-05-03 AT AT0322278A patent/AT365174B/de not_active IP Right Cessation
- 1978-05-03 BE BE187366A patent/BE866676A/xx not_active IP Right Cessation
- 1978-05-04 JP JP5365378A patent/JPS53141270A/ja active Pending
- 1978-05-04 HU HU78SI1626A patent/HU176882B/hu unknown
- 1978-05-04 IE IE902/78A patent/IE46950B1/en unknown
- 1978-05-04 FI FI781379A patent/FI781379A7/fi not_active Application Discontinuation
- 1978-05-04 CA CA302,606A patent/CA1105027A/en not_active Expired
- 1978-05-04 IT IT23035/78A patent/IT1096207B/it active
- 1978-05-05 NL NL7804887A patent/NL7804887A/xx unknown
- 1978-05-05 DE DE19782819874 patent/DE2819874A1/de not_active Withdrawn
- 1978-05-05 LU LU79606A patent/LU79606A1/xx unknown
-
1979
- 1979-11-13 US US06/093,366 patent/US4285952A/en not_active Expired - Lifetime
-
1981
- 1981-03-27 US US06/248,386 patent/US4372963A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FI781379A7 (fi) | 1978-11-06 |
| LU79606A1 (fr) | 1978-11-03 |
| HU176882B (en) | 1981-05-28 |
| US4285952A (en) | 1981-08-25 |
| IL54603A0 (en) | 1978-07-31 |
| GB1602458A (en) | 1981-11-11 |
| FR2389608A1 (en:Method) | 1978-12-01 |
| IE46950B1 (en) | 1983-11-16 |
| DK192778A (da) | 1978-11-06 |
| CA1105027A (en) | 1981-07-14 |
| AT365174B (de) | 1981-12-28 |
| NO781572L (no) | 1978-11-07 |
| ATA322278A (de) | 1981-05-15 |
| ZA782367B (en) | 1979-04-25 |
| JPS53141270A (en) | 1978-12-08 |
| IT7823035A0 (it) | 1978-05-04 |
| US4212875A (en) | 1980-07-15 |
| BE866676A (fr) | 1978-11-03 |
| US4372963A (en) | 1983-02-08 |
| IE780902L (en) | 1978-11-05 |
| FR2389608B1 (en:Method) | 1980-10-24 |
| NL7804887A (nl) | 1978-11-07 |
| IT1096207B (it) | 1985-08-26 |
| SE7805092L (sv) | 1978-11-06 |
| DE2819874A1 (de) | 1978-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2860900D1 (en) | Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them | |
| IL56115A (en) | 14-deoxy-14-glycoside-mutilin derivatives,process for their preparation and pharmaceutical and veterinary compositions containing them | |
| IL54842A (en) | 1-piperidino-phthalazine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL56206A0 (en) | New 1,2-benzothiazine-1,1-doxide derivatives, their preparation and pharmaceutical compositions containing them | |
| IL55109A (en) | 1-acyl-2-cyanoaziridines,process for their preparation and pharmaceutical compositions containing them | |
| DE2860862D1 (en) | Imidazolylethylene-oxyalkyloxy derivatives and their thio analogues, methods for their preparation and pharmaceutical compositions containing them | |
| GB2001624B (en) | Guanidine derivatives processes for their manufacture and pharmaceutical compositions containing them | |
| DE2861361D1 (en) | 1-n-acylated-4-o-glycosyl-6-o-glycosyl-1,3-diaminocyclitol derivatives, process for their preparation and pharmaceutical compositions containing them | |
| DE3062310D1 (en) | Pyrimidone derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| DE2964209D1 (en) | Spiro-furanohydantoin derivatives, process for their preparation and pharmaceutical compositions containing them | |
| IL54535A0 (en) | Novel -lactam derivatives, their preparation and pharmaceutical compositions containing them | |
| DE2966413D1 (en) | Pyrimidinone derivatives, processes for preparing them and pharmaceutical compositions containing them | |
| IL54069A (en) | 14,15-dihydro-20,21-dinoreburnamenin-14-ol derivatives,process for preparing them and pharmaceutical compositions containing them | |
| IL55894A (en) | 1-alkylenedithia (or oxathia) benzyl-4-heteroaryl-piperazine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL60468A (en) | 4-sulfamoylphenyl-2-phenyl-imino-1,3-thiazole derivatives,process for their preparation and pharmaceutical compositions containing them | |
| IL53766A0 (en) | 4-diphenylmethylene-1-hydroxybenzyl-piperidine derivatives, their preparation and pharmaceutical compositions containing them | |
| DE2861767D1 (en) | Cephalosprin derivatives, process for their preparation and pharmaceutical compositions containing them | |
| ZA793682B (en) | New piperidylbenzimidazolinone derivatives,processes for their preparation and pharmaceutical compositions containing them | |
| IL55857A (en) | Benzodioxanylcarbonyl-piperazinoquinazoline derivatives,their preparation and pharmaceutical compositions containing them | |
| DE2861796D1 (en) | Antiviral tetracyclononane derivatives, processes for their manufacture and pharmaceutical compositions containing them | |
| IL61099A (en) | 9-deoxy-6,9alpha-imino-delta6,8-pgi analogues,process for their preparation and pharmaceutical compositions containing them | |
| ZA782432B (en) | 2-benzyl-perhydroazepines,process for their preparation and pharmaceutical compositions containing them | |
| DE2861477D1 (en) | (omega-aminoalkoxy) bibenzyls, processes for their preparation and pharmaceutical compositions containing these substances | |
| IL55139A (en) | Substituted 2-cyclopropyl-chromones,process for their preparation and pharmaceutical compositions containing them | |
| DE2860212D1 (en) | 4-phenyl-8-amino-tetrahydroisoquinolines, pharmaceutical compositions containing them and process for preparation of these compositions |